RDNT RadNet Inc.

RadNet Enters the Long Island, New York Market with the Acquisition of Medical Arts Radiology

RadNet Enters the Long Island, New York Market with the Acquisition of Medical Arts Radiology

LOS ANGELES, Oct. 05, 2018 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective, fixed-site outpatient diagnostic imaging services today reported it acquired Medical Arts Radiology (“Medical Arts”), the owner of ten imaging centers in Long Island, New York.

The acquisition includes facilities in Bay Shore, Commack, East Setauket, Huntington, Massapequa, Patchogue, Plainview, Smithtown, West Babylon and Stony Brook.  The centers provide multimodality offerings including MRI, CT, PET/CT, X-ray, Ultrasound, Bone Density and Interventional procedures.  Having serviced the communities of Long Island for over 70 years, Medical Arts is one of the most established radiology practices in Nassau and Suffolk counties.

In addition to servicing the existing patient base, the Medical Arts centers will be instrumental in providing diagnostic imaging to the approximately 200,000 patients of Emblem’s AdvantageCare Physicans, for whom RadNet has contracted under a recently announced capitation agreement.

The ten centers annually generate approximately $40 million of patient revenue, perform approximately 180,000 imaging procedures and are accredited by the American College of Radiology (“ACR”).  The transaction will add over 350 full-time and part-time employees and access to approximately 15 radiologists who will serve the greater Nassau and Suffolk county areas.

Dr. Howard Berger, Chairman and Chief Executive Officer of RadNet, noted, “We are delighted to complete this important transaction.  After building a significant presence in the neighboring boroughs of New York City, including Queens, Brooklyn, Manhattan and the Bronx, we have been interested for some time in entering the Long Island marketplace.  Medical Arts is one of the most respected and well-known radiology practices in this market, and is an ideal practice from which to build.  Medical Arts provides high-quality service to the communities it serves and I believe that its culture aligns extremely well with that of RadNet.  I welcome the employees and affiliated physicians of Medical Arts to the RadNet family.”

Dr. Steven Tuzinkiewicz, the Chief Executive Officer of Medical Arts, added, “We are very pleased to be part of RadNet.  RadNet brings expertise, capital, scale and business acumen that can accelerate and expand our growth and success in Long Island.  Our similar cultures and passion for providing the highest quality medical services available make this transaction an ideal union.”

About RadNet, Inc.

RadNet, Inc. is the leading national provider of freestanding, fixed-site diagnostic imaging services in the United States based on the number of locations and annual imaging revenue. RadNet has a network of 304 owned and/or operated outpatient imaging centers. RadNet's core markets include California, Maryland, Delaware, New Jersey and New York. In addition, RadNet provides radiology information technology solutions, teleradiology professional services and other related products and services to customers in the diagnostic imaging industry.  Together with affiliated radiologists, and inclusive of full-time and per diem employees and technicians, RadNet has a total of over 7,500 employees.  For more information, visit

CONTACTS:

RadNet, Inc.

Mark Stolper, 310-445-2800

Executive Vice President and Chief Financial Officer

EN
05/10/2018

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on RadNet Inc.

 PRESS RELEASE

DeepHealth Unveils Industry’s Most Comprehensive Portfolio of Native C...

DeepHealth Unveils Industry’s Most Comprehensive Portfolio of Native Clinical AI Solutions at ECR 2026  DeepHealth is introducing in Europe its cloud-first integrated portfolio combining clinical AI, multi-modality viewing and reporting, which is designed to improve outcomes, efficiency and access to care VIENNA, March 04, 2026 (GLOBE NEWSWIRE) -- DeepHealth, a global leader in AI-powered health informatics and a wholly owned subsidiary of RadNet, Inc. (NASDAQ: RDNT), today unveils at ECR 2026 the industry's most comprehensive portfolio of native clinical AI solutions and services acros...

 PRESS RELEASE

RadNet, Inc. Reminds Investors of the Dedicated Conference Call and Pr...

RadNet, Inc. Reminds Investors of the Dedicated Conference Call and Presentation About the Recently Completed Acquisition of Gleamer SAS LOS ANGELES, March 04, 2026 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of owned and operated outpatient imaging centers, reminds investors that on Thursday, March 5, 2026, investors are invited to join a dedicated conference call and presentation to hear more details about the recently completed acquisition of Gleamer SAS and RadNet’s Digital H...

 PRESS RELEASE

RadNet, Inc. to Present at the Raymond James 47th Annual Institutional...

RadNet, Inc. to Present at the Raymond James 47th Annual Institutional Investors Conference on Tuesday, March 3rd, 2026 LOS ANGELES, March 02, 2026 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of fully-owned and operated outpatient imaging centers, today announced that Mark Stolper, Executive Vice President and Chief Financial Officer will be presenting at the Raymond James 47th Annual Institutional Investors Conference in Orlando, Florida on, Tuesday, March 3, 2026 at 2:15 p.m. E...

 PRESS RELEASE

RadNet Reports Fourth Quarter 2025 Results, Including Record Revenue a...

RadNet Reports Fourth Quarter 2025 Results, Including Record Revenue and Adjusted EBITDA⁽¹⁾ and Releases 2026 Financial Guidance Total Company Revenue increased 14.8% to a quarterly record of $547.7 million in the fourth quarter of 2025 from $477.1 million in the fourth quarter of 2024; Revenue from the Digital Health reportable segment (inclusive of intersegment revenue) increased 48.2% to $27.9 million in the fourth quarter of 2025 from $18.9 million in the fourth quarter of 2024Total Company Adjusted EBITDA(1) was a quarterly record of $87.7 million in the fourth quarter of 2025 as compa...

 PRESS RELEASE

RadNet Acquires Gleamer, Making RadNet’s DeepHealth the Largest Provid...

RadNet Acquires Gleamer, Making RadNet’s DeepHealth the Largest Provider of Radiology Clinical AI Solutions Worldwide Based in Paris, France, Gleamer serves over 700 customer contracts worldwide with a broad portfolio of FDA-cleared and CE-marked solutions for musculoskeletal, breast, lung and neurologic applications.Gleamer’s leadership in routine imaging, and particularly X-ray, is unparalleled through the breadth and scale of its cloud-first AI solutions. DeepHealth, combined with Gleamer’s solutions will provide the industry’s most comprehensive portfolio of native clinical AI solutio...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch